Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT

Gurnari, C., Koster, L., Baaij, L. et al. (21 more authors) (2023) Allogeneic hematopoietic cell transplantation for Vexas syndrome: results of a multicenter study from the chronic malignancies and autoimmune disease working parties of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 708.

Metadata

Authors/Creators:
  • Gurnari, C.
  • Koster, L.
  • Baaij, L.
  • Heiblig, M.
  • Yakoub-Agha, I.
  • Passweg, J.R.
  • Clay, J.
  • Kuball, J.
  • Rambaldi, A.
  • Hayden, P.J.
  • Badoglio, M.
  • Onida, F.
  • Scheid, C.
  • Franceschini, F.
  • Mekinian, A.
  • Savic, S.
  • Voso, M.T.
  • Drozd-Sokolowska, J.
  • Snowden, J. ORCID logo https://orcid.org/0000-0001-6819-3476
  • Raj, K.
  • Alexander, T.
  • Robin, M.
  • Greco, R.
  • McLornan, D.P.
Copyright, Publisher and Additional Information: © 2023 by The American Society of Hematology.
Keywords: Biomedical and Clinical Sciences; Cardiovascular Medicine and Haematology; Clinical Sciences; Cancer; Genetics; Transplantation; Regenerative Medicine; Stem Cell Research; Autoimmune Disease; Clinical Research; Hematology; Rare Diseases; Stem Cell Research - Nonembryonic - Human; Inflammatory and immune system
Dates:
  • Published (online): 28 November 2023
  • Published: 2 November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 13 Dec 2023 11:20
Last Modified: 13 Dec 2023 12:28
Status: Published
Publisher: American Society of Hematology
Refereed: Yes
Identification Number: https://doi.org/10.1182/blood-2023-174385

Export

Statistics